OUT OF STOCK

RAPID TEST

The COVID-19 IgG and IgM Rapid Test accurately identifies the antibodies that develop after exposure to coronavirus — and delivers results in as little as 10 minutes.

Not all Covid-19 antibody tests are created equal. The Rapid Test exclusively offered by Premier Biotech is backed by research that demonstrates a 93% sensitivity rate. For details on the research, visit our Resources page.

Key advantages

  • Confident COVID-19 Results
  • Fast results in 10 minutes
  • Easy to use
  • Highly accurate
  • 60 tests per case
  • Prompt shipping and delivery

KIT CONTENTS INCLUDE:

  • Test cassette
  • Desiccant, buffer, alcohol swab
  • Sterile lancet
  • Disposable capillary
  • Package insert/procedure guide

DONOR DRIVEN PROCESS.

NO NEED FOR COLLECTOR TO TOUCH DEVICE UNTIL PROCESS COMPLETE.​

Donor Collection

Secure Screening

Results in Minutes

IMPORTANT INFORMATION

On March 16, the U.S. government took an unprecedented step towards access to Coronavirus Disease (COVID-19) testing by allowing developers of certain tests to commercialize the products in the U.S. without the requirement for an FDA approval or Emergency Use Authorization (EUA)i. To comply with the regulation, the following statements must be included in any test reports using the COVID-19 Rapid Test: 

  • This test has not been reviewed by the FDA. 
  • Negative results do not rule out SARS-CoV-2 infection, particularly in those who have been in contact with the virus. Follow-up testing with a molecular diagnostic should be considered to rule out infection in these individuals. 
  • Results from antibody testing should not be used as the sole basis to diagnose or exclude SARS-CoV-2 infection or to inform infection status. 
  • Positive results may be due to past or present infection with non-SARS-CoV-2 coronavirus strains, such as coronavirus HKU1, NL63, OC43, or 229E. In addition, we have included these statements throughout the product package insert, aligning with the technical sections to which they pertain.